NCT03527745View on ClinicalTrials.gov

Albendazole Dose Finding and Pharmacokinetics in Children and Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

700

Participants

Timeline

Start Date

October 23, 2018

Primary Completion Date

April 17, 2019

Study Completion Date

April 17, 2019

Conditions
TrichuriasisHookworm Infections
Interventions
DRUG

Albendazole

Single dose of albendazole (200mg, dependent on treatment cohort)

DRUG

Albendazole

Single dose of albendazole (400mg, dependent on treatment cohort)

DRUG

Albendazole

Single dose of albendazole (600mg, dependent on treatment cohort)

DRUG

Albendazole

Single dose of albendazole (800mg, dependent on treatment cohort)

DRUG

Placebo

Matching placebo tablets will be obtained from Fagron, Germany.

Trial Locations (1)

Unknown

Centre Suisse de Recherches Scientifiques en Côte d'Ivoire (CSRS), Abidjan

All Listed Sponsors
collaborator

Centre Suisse de Recherches Scientifiques en Cote d'Ivoire

OTHER

lead

Jennifer Keiser

OTHER

NCT03527745 - Albendazole Dose Finding and Pharmacokinetics in Children and Adults | Biotech Hunter | Biotech Hunter